Encapsulation of Hemoglobin in Liposomes

[1]  C. Alving,et al.  Complement activation in rats by liposomes and liposome-encapsulated hemoglobin: evidence for anti-lipid antibodies and alternative pathway activation. , 1994, Biochemical and biophysical research communications.

[2]  B. Spargo,et al.  Transient changes in the mononuclear phagocyte system following administration of the blood substitute liposome-encapsulated haemoglobin. , 1994, Biomaterials.

[3]  R. Roth.  Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. , 1994, Blood.

[4]  A S Rudolph,et al.  Lyophilized liposome encapsulated hemoglobin: Evaluation of hemodynamic, biochemical, and hematologic responses , 1994, Critical care medicine.

[5]  B. Goins,et al.  Circulation persistence and biodistribution of lyophilized liposome‐encapsulated hemoglobin: An oxygen‐carrying resuscitative fluid , 1994, Critical care medicine.

[6]  M. Bally,et al.  The presence of GM1 in liposomes with entrapped doxorubicin does not prevent RES blockade. , 1993, Biochimica et biophysica acta.

[7]  R. Maier,et al.  Liposome‐encapsulated hemoglobin inhibits tumor necrosis factor release from rabbit alveolar macrophages by a posttranscriptional mechanism , 1992, Journal of leukocyte biology.

[8]  G. Feuerstein,et al.  A new salutary resuscitative fluid: liposome encapsulated hemoglobin/hypertonic saline solution. , 1992, The Journal of trauma.

[9]  F. Ligler,et al.  Biological responses to exchange transfusion with liposome-encapsulated hemoglobin. , 1992, Circulatory shock.

[10]  L. Huang,et al.  Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.

[11]  S. Takeoka,et al.  Preparation of dehydrated powder of hemoglobin vesicles , 1992 .

[12]  B. Goins,et al.  In vivo biodistribution of a radiolabeled blood substitute: 99mTc-labeled liposome-encapsulated hemoglobin in an anesthetized rabbit. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[13]  A. Gabizon,et al.  Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. , 1991, Biochimica et biophysica acta.

[14]  H. Yoshioka.  Surface modification of haemoglobin-containing liposomes with polyethylene glycol prevents liposome aggregation in blood plasma. , 1991, Biomaterials.

[15]  A. Rudolph,et al.  Dry storage of liposome-encapsulated hemoglobin: a blood substitute. , 1990, Cryobiology.

[16]  M. Bally,et al.  The Binding of Phosphatidylglycerol Liposomes to Rat Platelets Is Mediated by Complement , 1990, Thrombosis and Haemostasis.

[17]  T. Yue,et al.  Biological responses to liposome-encapsulated hemoglobin (LEH) are improved by a PAF antagonist. , 1990, Circulatory shock.

[18]  G. Feuerstein,et al.  Improved biological properties of synthetic distearoyl phosphatidyl choline-based liposome in the conscious rat. , 1990, Circulatory shock.

[19]  G. Feuerstein,et al.  Characterization of hemodynamic, hematologic, and biochemical responses to administration of liposome-encapsulated hemoglobin in the conscious, freely moving rat. , 1989, Circulatory shock.

[20]  R. Schubert,et al.  Preparation of hemoglobin-containing liposomes using octyl glucoside and octyltetraoxyethylene. , 1989, Biochimica et biophysica acta.

[21]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[22]  A. Rudolph,et al.  The freeze-dried preservation of liposome encapsulated hemoglobin: a potential blood substitute. , 1988, Cryobiology.

[23]  Inoue Keizo,et al.  Generation of toxic phospholipid(s) during oxyhemoglobin-induced peroxidation of phosphatidylcholines , 1988 .

[24]  E. Evans,et al.  Thermomechanical and transition properties of dimyristoylphosphatidylcholine/cholesterol bilayers. , 1988, Biochemistry.

[25]  I. Miller,et al.  Cardiorespiratory effects of exchange transfusions with synthetic erythrocytes in rats , 1987, Critical care medicine.

[26]  C. T. White,et al.  Synergistic toxicity of endotoxin and hemoglobin. , 1986, The Journal of laboratory and clinical medicine.

[27]  R. Beissinger,et al.  Liposome-encapsulated hemoglobin as a red cell surrogate. Preparation scale-up. , 1986, ASAIO transactions.

[28]  J. Szebeni,et al.  Lipid peroxidation in hemoglobin-containing liposomes. Effects of membrane phospholipid composition and cholesterol content. , 1986, Biochimica et biophysica acta.

[29]  C. Hunt,et al.  Synthesis and evaluation of a prototypal artificial red cell. , 1985, Science.

[30]  H. Hauser,et al.  Encapsulation of hemoglobin in phospholipid liposomes: characterization and stability. , 1985, Biochemistry.

[31]  L. Djordjevich,et al.  Synthetic erythrocytes from lipid encapsulated hemoglobin. , 1980, Experimental hematology.

[32]  G. Gregoriadis,et al.  Stability of liposomes in vivo and in vitro is promoted by their cholesterol content and the presence of blood cells. , 1979, Biochemical and biophysical research communications.

[33]  G. Gregoriadis,et al.  The effect of lipid composition on the stability of liposomes in vivo [proceedings]. , 1979, Biochemical Society transactions.

[34]  R L Juliano,et al.  The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. , 1975, Biochemical and biophysical research communications.

[35]  E. Oldfield,et al.  Effects of cholesterol and cholesterol derivatives on hydrocarbon chain mobility in lipids. , 1971, Biochemical and biophysical research communications.

[36]  K. Suzuki,et al.  Effect of neo red cells on hemodynamics and blood gas transport in canine hemorrhagic shock and its safety for vital organs. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[37]  E. Tsuchida.  Stabilized hemoglobin vesicles. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[38]  F. Ligler,et al.  Inclusion of ganglioside GM1 into liposome encapsulated hemoglobin does not extend circulation persistence at clinically relevant doses. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[39]  B. Goins,et al.  Circulation profile of technetium-99m labeled liposome encapsulated hemoglobin in a 10% or 50% rat hypovolemic shock model. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[40]  L. Spiryda,et al.  Effects of liposome encapsulated hemoglobin on the reticuloendothelial system. , 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[41]  H M Patel,et al.  Serum opsonins and liposomes: their interaction and opsonophagocytosis. , 1992, Critical reviews in therapeutic drug carrier systems.

[42]  F. Ligler,et al.  Liposome encapsulated hemoglobin: stabilization, encapsulation, and storage. , 1989, Progress in clinical and biological research.

[43]  A. Rudolph,et al.  The reduction of methemoglobin levels by antioxidants. , 1988, Hemoglobin.

[44]  K. Vandegriff,et al.  Liposome-encapsulated hemoglobin: oxygen binding properties and respiratory function. , 1988, Biomaterials, artificial cells, and artificial organs.

[45]  B. Gaber,et al.  Liposome-encapsulated hemoglobin as an artificial oxygen-carrying system. , 1987, Methods in enzymology.

[46]  Charles Tanford,et al.  The hydrophobic effect , 1980 .